These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25267010)
1. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines. Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010 [TBL] [Abstract][Full Text] [Related]
2. Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F. Lin AC; Liao CW; Lin SW; Huang CY; Liou CJ; Lai YS Vet J; 2015 Aug; 205(2):254-62. PubMed ID: 25882637 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines. Chang CY; Chiou PP; Chen WJ; Li YH; Yiu JC; Cheng YH; Chen SD; Lin CT; Lai YS Res Vet Sci; 2010 Apr; 88(2):285-93. PubMed ID: 19748110 [TBL] [Abstract][Full Text] [Related]
4. Bupivacaine induces apoptosis through caspase-dependent and -independent pathways in canine mammary tumor cells. Chiu YS; Cheng YH; Lin SW; Chang TS; Liou CJ; Lai YS Res Vet Sci; 2015 Jun; 100():232-8. PubMed ID: 25843897 [TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line. Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813 [TBL] [Abstract][Full Text] [Related]
6. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27. Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118 [TBL] [Abstract][Full Text] [Related]
7. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors. Zhou C; Lin Z; Li X; Zhang D; Song P Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947 [TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors. Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526 [TBL] [Abstract][Full Text] [Related]
10. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT. Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424 [TBL] [Abstract][Full Text] [Related]
11. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds. Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors. Guillemette S; Rico C; Godin P; Boerboom D; Paquet M J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004 [TBL] [Abstract][Full Text] [Related]
13. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker. Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656 [TBL] [Abstract][Full Text] [Related]
14. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells. Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298 [TBL] [Abstract][Full Text] [Related]
15. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line. Nagamatsu K; Tsuchiya F; Oguma K; Maruyama H; Kano R; Hasegawa A Res Vet Sci; 2008 Feb; 84(1):49-55. PubMed ID: 17537469 [TBL] [Abstract][Full Text] [Related]
16. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603 [TBL] [Abstract][Full Text] [Related]
17. Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells. Pawłowski KM; Mucha J; Majchrzak K; Motyl T; Król M BMC Vet Res; 2013 Jun; 9():119. PubMed ID: 23773525 [TBL] [Abstract][Full Text] [Related]
18. Establishment of 5-Fluorouracil-resistant canine mammary tumor cell line. Zhou B; Zhang D; Pei SM; Zhang H; Du HC; Jin YP; Lin DG Pol J Vet Sci; 2017 Mar; 20(1):103-110. PubMed ID: 28525328 [TBL] [Abstract][Full Text] [Related]
19. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026. Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]